[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

2019 Marburgvirus Infections (Marburg Hemorrhagic Fever) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline companies from advancing their products. Marburgvirus Infections (Marburg Hemorrhagic Fever) Report Description The H1-2019 pipeline review report on Marburgvirus Infections (Marburg Hemorrhagic Fever) is a comprehensive ...

March 2019 55 pages

2019 Measles (rubeola) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Measles (rubeola) pipeline companies from advancing their products. Measles (rubeola) Report Description The H1-2019 pipeline review report on Measles (rubeola) is a comprehensive study on drug candidates ...

March 2019 40 pages

2019 Meningitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Meningitis pipeline companies from advancing their products. Meningitis Report Description The H1-2019 pipeline review report on Meningitis is a comprehensive study on drug candidates across different ...

March 2019 30 pages

2019 Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline companies from advancing their products. Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Report Description The H1-2019 pipeline review report on Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections ...

March 2019 40 pages

2019 Middle East Respiratory Syndrome (MERS) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Middle East Respiratory Syndrome (MERS) pipeline companies from advancing their products. Middle East Respiratory Syndrome (MERS) Report Description The H1-2019 pipeline review report on Middle East Respiratory Syndrome (MERS) is a comprehensive ...

March 2019 65 pages

2019 Mumps R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Mumps pipeline companies from advancing their products. Mumps Report Description The H1-2019 pipeline review report on Mumps is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Neisseria meningitidis Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Neisseria meningitidis Infections pipeline companies from advancing their products. Neisseria meningitidis Infections Report Description The H1-2019 pipeline review report on Neisseria meningitidis Infections ... and universities participating in the Neisseria meningitidis Infections product pipeline are provided. ...

March 2019 65 pages

2019 Neutropenia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Neutropenia pipeline companies from advancing their products. Neutropenia Report Description The H1-2019 pipeline review report on Neutropenia is a comprehensive study on drug candidates across different ...

March 2019 70 pages

2019 Onychomycosis (Nail fungus) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Onychomycosis (Nail fungus) pipeline companies from advancing their products. Onychomycosis (Nail fungus) Report Description The H1-2019 pipeline review report on Onychomycosis (Nail fungus) ... providers and universities participating in the Onychomycosis (Nail fungus) product pipeline are provided. Company ...

March 2019 55 pages

2019 Osteomyelitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Osteomyelitis pipeline companies from advancing their products. Osteomyelitis Report Description The H1-2019 pipeline review report on Osteomyelitis is a comprehensive study on drug candidates across different ...

March 2019 34 pages

2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Paroxysmal Nocturnal Hemoglobinuria (PNH) pipeline companies from advancing their products. Paroxysmal Nocturnal Hemoglobinuria (PNH) Report Description The H1-2019 pipeline review report on Paroxysmal Nocturnal Hemoglobinuria (PNH) is a comprehensive study on drug ...

March 2019 65 pages

2019 Pertussis (Whooping Cough) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Pertussis (Whooping Cough) pipeline companies from advancing their products. Pertussis (Whooping Cough) Report Description The H1-2019 pipeline review report on Pertussis (Whooping Cough) ... providers and universities participating in the Pertussis (Whooping Cough) product pipeline are provided. Company ...

March 2019 72 pages

2019 Plague R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Plague pipeline companies from advancing their products. Plague Report Description The H1-2019 pipeline review report on Plague is a comprehensive study on drug candidates across different ...

March 2019 45 pages

2019 Poliomyelitis (Polio) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Poliomyelitis (Polio) pipeline companies from advancing their products. Poliomyelitis (Polio) Report Description The H1-2019 pipeline review report on Poliomyelitis (Polio) is a comprehensive study on drug candidates ...

March 2019 66 pages

2019 Progressive Multifocal Leukoencephalopathy R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Progressive Multifocal Leukoencephalopathy pipeline companies from advancing their products. Progressive Multifocal Leukoencephalopathy Report Description The H1-2019 pipeline review report on Progressive Multifocal Leukoencephalopathy is a comprehensive study on drug ...

March 2019 40 pages

2019 Pseudomonas aeruginosa Pneumonia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Pseudomonas aeruginosa Pneumonia pipeline companies from advancing their products. Pseudomonas aeruginosa Pneumonia Report Description The H1-2019 pipeline review report on Pseudomonas aeruginosa Pneumonia ... and universities participating in the Pseudomonas aeruginosa Pneumonia product pipeline are provided. ...

March 2019 35 pages

2019 Pyelonephritis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Pyelonephritis pipeline companies from advancing their products. Pyelonephritis Report Description The H1-2019 pipeline review report on Pyelonephritis is a comprehensive study on drug candidates across different ...

March 2019 55 pages

2019 Q Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Q Fever pipeline companies from advancing their products. Q Fever Report Description The H1-2019 pipeline review report on Q Fever is a comprehensive study on drug candidates ...

March 2019 24 pages

2019 Rabies R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Rabies pipeline companies from advancing their products. Rabies Report Description The H1-2019 pipeline review report on Rabies is a comprehensive study on drug candidates across different ...

March 2019 60 pages

2019 Resistant Pseudomonas aeruginosa Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Resistant Pseudomonas aeruginosa Infections pipeline companies from advancing their products. Resistant Pseudomonas aeruginosa Infections Report Description The H1-2019 pipeline review report on Resistant Pseudomonas aeruginosa Infections is a comprehensive study on drug ...

March 2019 55 pages

2019 Rhinovirus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Rhinovirus Infections pipeline companies from advancing their products. Rhinovirus Infections Report Description The H1-2019 pipeline review report on Rhinovirus Infections is a comprehensive study on drug candidates ...

March 2019 51 pages

2019 Rotavirus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Rotavirus Infections pipeline companies from advancing their products. Rotavirus Infections Report Description The H1-2019 pipeline review report on Rotavirus Infections is a comprehensive study on drug candidates ...

March 2019 50 pages

2019 Rubella (German Measles) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... the Rubella (German Measles) pipeline companies from advancing their products. Rubella (German Measles) Report Description The H1-2019 pipeline review report on Rubella (German Measles) is ... license providers and universities participating in the Rubella (German Measles) product pipeline are provided. Company ...

March 2019 40 pages

2019 Schistosomiasis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Schistosomiasis pipeline companies from advancing their products. Schistosomiasis Report Description The H1-2019 pipeline review report on Schistosomiasis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Severe Acute Respiratory Syndrome (SARS) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... some of the Severe Acute Respiratory Syndrome (SARS) pipeline companies from advancing their products. Severe Acute Respiratory Syndrome (SARS) Report Description The H1-2019 pipeline review report on Severe Acute Respiratory Syndrome (SARS) is a comprehensive ...

March 2019 65 pages

2019 Smallpox R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Smallpox pipeline companies from advancing their products. Smallpox Report Description The H1-2019 pipeline review report on Smallpox is a comprehensive study on drug candidates across different ...

March 2019 50 pages

2019 Streptococcus pyogenes Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Streptococcus pyogenes Infections pipeline companies from advancing their products. Streptococcus pyogenes Infections Report Description The H1-2019 pipeline review report on Streptococcus pyogenes Infections ... and universities participating in the Streptococcus pyogenes Infections product pipeline are provided. ...

March 2019 45 pages

2019 Tetanus R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Tetanus pipeline companies from advancing their products. Tetanus Report Description The H1-2019 pipeline review report on Tetanus is a comprehensive study on drug candidates across different ...

March 2019 65 pages

2019 Thalassemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Thalassemia pipeline companies from advancing their products. Thalassemia Report Description The H1-2019 pipeline review report on Thalassemia is a comprehensive study on drug candidates across different ...

March 2019 120 pages

2019 Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... of the Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) pipeline companies from advancing their products. Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) Report Description The H1-2019 pipeline review report on Thrombotic Thrombocytopenic Purpura (Moschcowitz syndrome) is a comprehensive ...

March 2019 30 pages

2019 Tinea pedis (Athlete Foot) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Tinea pedis (Athlete Foot) pipeline companies from advancing their products. Tinea pedis (Athlete Foot) Report Description The H1-2019 pipeline review report on Tinea pedis (Athlete Foot) is a comprehensive study on drug ...

March 2019 40 pages

2019 Toxoplasmosis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Toxoplasmosis pipeline companies from advancing their products. Toxoplasmosis Report Description The H1-2019 pipeline review report on Toxoplasmosis is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Tularaemia R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Tularaemia pipeline companies from advancing their products. Tularaemia Report Description The H1-2019 pipeline review report on Tularaemia is a comprehensive study on drug candidates across different ...

March 2019 40 pages

2019 Typhoid Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Typhoid Fever pipeline companies from advancing their products. Typhoid Fever Report Description The H1-2019 pipeline review report on Typhoid Fever is a comprehensive study on drug candidates ...

March 2019 45 pages

2019 Vancomycin-Resistant Enterococcus faecium Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Vancomycin-Resistant Enterococcus faecium Infections pipeline companies from advancing their products. Vancomycin-Resistant Enterococcus faecium Infections Report Description The H1-2019 pipeline review report on Vancomycin-Resistant Enterococcus faecium Infections is a comprehensive study ...

March 2019 69 pages

2019 Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline companies from advancing their products. Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Report Description The H1-2019 pipeline review report on Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections ...

March 2019 45 pages

2019 Ventilator Associated Pneumonia (VAP) R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Ventilator Associated Pneumonia (VAP) pipeline companies from advancing their products. Ventilator Associated Pneumonia (VAP) Report Description The H1-2019 pipeline review report on Ventilator Associated Pneumonia (VAP) is a comprehensive study on drug ...

March 2019 75 pages

2019 Warts R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the Warts pipeline companies from advancing their products. Warts Report Description The H1-2019 pipeline review report on Warts is a comprehensive study on drug candidates across different ...

March 2019 75 pages

2019 West Nile Virus Infections R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... holding some of the West Nile Virus Infections pipeline companies from advancing their products. West Nile Virus Infections Report Description The H1-2019 pipeline review report on West Nile Virus Infections is a comprehensive study on drug ...

March 2019 50 pages

2019 Western Equine Encephalitis R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... Western Equine Encephalitis pipeline companies from advancing their products. Western Equine Encephalitis Report Description The H1-2019 pipeline review report on Western Equine Encephalitis ... providers and universities participating in the Western Equine Encephalitis product pipeline are provided. Company ...

March 2019 35 pages

2019 Yellow Fever R&D Pipeline Drugs, Companies, Trials and Developments

US$ 1,979.00

... are holding some of the Yellow Fever pipeline companies from advancing their products. Yellow Fever Report Description The H1-2019 pipeline review report on Yellow Fever is a comprehensive study on drug candidates ...

March 2019 55 pages

2019 Abdominal Abscess Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Abdominal Abscess Ongoing Clinical Trials Study” analyzes the current scenario of all active Abdominal Abscess trials across the world. The report presents ...

February 2019 32 pages

2019 Abdominal Aortic Aneurysm Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Abdominal Aortic Aneurysm Ongoing Clinical Trials Study” analyzes the current scenario of all active Abdominal Aortic Aneurysm trials across the world. The report ...

February 2019 49 pages

2019 Abdominal Obesity Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Abdominal Obesity Ongoing Clinical Trials Study” analyzes the current scenario of all active Abdominal Obesity trials across the world. The report presents ...

February 2019 41 pages

2019 Abdominal Pain Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Abdominal Pain Ongoing Clinical Trials Study” analyzes the current scenario of all active Abdominal Pain trials ... researched for administering Abdominal Pain patients are identified The report includes panorama of ongoing Abdominal Pain clinical trials across ...

February 2019 135 pages

2019 Abnormal Uterine Bleeding Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

... trial research report- “2019 Abnormal Uterine Bleeding Ongoing Clinical Trials Study” analyzes the current scenario of all active Abnormal Uterine Bleeding trials across the world. The report ...

February 2019 47 pages

2019 Abortion Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Abortion Ongoing Clinical Trials Study” analyzes the current scenario of all active Abortion trials across the world. The report presents top level analysis ...

February 2019 117 pages

2019 Abscess Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Abscess Ongoing Clinical Trials Study” analyzes the current scenario of all active Abscess trials across the world. The report presents top level analysis ...

February 2019 55 pages

2019 Acid Indigestion Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Acid Indigestion Ongoing Clinical Trials Study” analyzes the current scenario of all active Acid Indigestion trials ... for administering Acid Indigestion patients are identified The report includes panorama of ongoing Acid Indigestion clinical trials across ...

February 2019 49 pages

2019 Acidity Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 1,979.00

The ongoing clinical trial research report- “2019 Acidity Ongoing Clinical Trials Study” analyzes the current scenario of all active Acidity trials across the world. The report presents top level analysis ...

February 2019 36 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers